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Very soon, noninvasive testing will be able to evaluate
valvular heart disease as well as it can now determine the
presence or absence of coronary artery disease. Echocardi-
ography and Doppler evaluation of mitral and aortic valve
malfunction are being developed and soon will be able to
predict degrees of stenosis and insufficiency with great ac-
curacy. Whether these efforts will suffice to determine the
need for surgery, operative risk and prognosis is not clear,
and indeed is doubtful. As thoughtful physicians, this sub-
ject presents us with a dilemma. Simply stated, we are being
asked to permit limited yet useful scientific data to guide
us in making major decisions regarding cardiac surgery with
its attendant risks. Authors writing about these new methods
are "suggesting" that noninvasive data "may be" good
enough to warrant a decision of whether or not to operate.
Such an approach is not always good medicine. Scientific
data presented in these terms ignore many other pertinent
considerations that bear heavily on any decisions in treating
valvular heart disease. A brief review of a few of these is
in order.
Cost. Patients want the very best care and cost is not
their foremost concern. In a court of law, the argument that
a test was omitted because of its expense is meaningless
when the death or injury of a patient is under discussion.
No jury would ever permit cost to interfere with optimal
patient care. Furthermore, no single noninvasive test can
evaluate cardiovascular function completely. Multiple tests
including exercise stress, multiple forms of echocardiog-
raphy, Doppler ultrasound and nuclear testing are needed.
The cost of all of these together, however, frequently ex-
ceeds that of a single cardiac catheterization which would
probably settle the issue conclusively.
Which tests are decision-making? Not all diagnostic
studies have the same probability or possibility of conclu-
sively determining the status of cardiovascular disease. The
presence or absence of occlusive coronary artery disease
may be inferred from nuclear imaging and echocardiography
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with a less than optimal degree of sensitivity and specificity.
In fact, abnormalities of perfusion detected by thallium per-
fusion scanning and abnormalities of left ventricular func-
tion determined by nuclear angiography only lead to more
questions, usually requiring cardiac angiography. Echo-
cardiography may be diagnostic for prolapse of the mitral
valve or even septal defects. Doppler ultrasound study is
impressive in its ability to evaluate valvular stenosis and
insufficiency, but what degree of error is acceptable before
we decide it is not good enough? In this era of cost con-
tainment and Diagnosis Related Groups, the clinician must
ask which test is apt to solve the problem at hand with least
effort, cost and risk. Noninvasive tests are relatively ex-
pensive but, of more importance, they have a much greater
error than full hemodynamic evaluation with angio-
cardiography.
Unsuspected disease. Part of any preoperative patient
study includes evaluation to rule out unsuspected disease.
Which noninvasive tests can conclusively rule out the pres-
ence of pulmonary hypertension, small intracardiac shunts,
vascular abnormalities as well as multiple other unsuspected
conditions (1,2) that might influence the conduct of cardiac
surgery? After all, invasive testing is utilized not only to
determine what is present, but also to eliminate and confirm
what is not present to make the procedure safer and more
effective for the surgeon. The risk of cardiac catheterization
is quite low (3,4). Despite preliminary reports (5,6), no one
knows how high the risk of not performing cardiac cathe-
terization can be in a broad spectrum of patients of all ages.
At this point, we must once again decide when good enough
is really good enough.
Coronary arteries. Many noninvasive efforts useful for
evaluating valvular disease fail to confront the real problem
which is complete cardiac evaluation. Even if valve disease
exists, what about the coronary arteries? Are they to be
ignored? Can left ventricular dysfunction be assumed to be
secondary to valve disease, eliminating the possibility of
coronary artery disease? Statistically, patients with aortic
valve disease who do not have angina have a very good
chance of having normal coronary arteries or at least coro-
nary arteries without obstruction. It has been proposed that
under these circumstances, coronary arteriography is not
indicated (6). This approach is an impersonal or comput-
erized style of medicine. Patients subjected to this reasoning
no longer exist as individuals, but only as subjects of sta-
tistical manipulation. This is potentially bad medicine. The
responsible physician must buffer these impersonal scientific
mathematical decisions with a reasoned approach to mul-
tifactorial medical problems which include the patient he or
she is treating. I believe it is well accepted that increased
severity of coronary artery disease will increase the risk of
valvular surgery (7,8). Thus, I cannot accept the argument
that if the coronary arteries are statistically normal, they
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should not be examined. In the many patients who have
combined valvular and coronary disease, bypass surgery
may be life-saving or, at least, lead to a much improved
clinical condition than if were it not done.
Conclusions. The term "good enough" only excuses
less than optimal patient care. From an ethical standpoint,
we are obligated to provide our best efforts to every patient.
If we as physicians are to do no harm, our knowledge of
the patient's condition must be as complete as possible. To
state that a noninvasive or invasive test is 90% accurate is
good, but 99% is better. If another method is possible, and
if its accuracy is better than 90% and it is not as risky or
difficult, I believe it should be utilized. Granted, there is a
point of diminishing return, but this is the art of medicine
that complements the science. Thus, if any test such as
cardiac catheterization can increase the success rate of the
diagnostic efforts from 90 to 99% with no substantial in-
crease in risk, while at the same time lowering the surgical
risk, the decision should be obvious.
As responsible physicians we constantly guard against
the use of incomplete and therefore faulty scientific infor-
mation in order to assure patients our best care. Under
certain circumstances, it may be necessary to limit any pre-
operative evaluation to noninvasive testing if the alternative
is unusually hazardous, difficult or even impossible. How-
ever, full invasive evaluation that includes details of anat-
omy and physiology is still unequalled. The use of nonilJ-
vasive tests to guide the decision to operate or withhold
surgery may be attractive economically and scientifically,
but it is not necessarily optimal medical practice.
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